Title:
METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSION WITH COMBINATIONS OF RALINEPAG AND OTHER AGENTS
Document Type and Number:
Japanese Patent JP2023029865
Kind Code:
A
Abstract:
To provide a composition used in a method to treat human pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).SOLUTION: The present invention provides a composition containing ralinepag, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, to be used in combination with prostanoid, or one or more of soluble guanylate cyclase (sGC) stimulators.SELECTED DRAWING: Figure 12
Inventors:
Clapp, Lucy H.
Beehan, Dominic Pea.
Adams, John W.
Beehan, Dominic Pea.
Adams, John W.
Application Number:
JP2022185917A
Publication Date:
March 07, 2023
Filing Date:
November 21, 2022
Export Citation:
Assignee:
Arena Pharmaceuticals, Inc.
Clapp, Lucy H.
Clapp, Lucy H.
International Classes:
A61K31/19; A61K31/416; A61K31/44; A61K31/506; A61K31/519; A61K31/5377; A61K31/5575; A61K31/5578; A61K45/00; A61P7/02; A61P9/12; A61P11/00; A61P43/00; C07D213/70; C07D239/52; C07D333/34; C07D405/04; C07D471/04; C07D487/04
Attorney, Agent or Firm:
Yoshihiro Kiyohara
Previous Patent: METHOD FOR MANUFACTURING ADDITIVE PRODUCT IN THREE DIMENSIONS
Next Patent: Production of parvoviral vectors
Next Patent: Production of parvoviral vectors